FDA official logo
GSRS logo
PFDA official logo

RESCINNAMINE

  • UNII: Q6W1F7DJ2D
  • Formula: C35H42N2O9
  • Preferred Substance Name: RESCINNAMINE
  • InChIKey: SZLZWPPUNLXJEA-QEGASFHISA-N

  • 24815-24-5
  • 246-471-8
  • (3.BETA.,16.BETA.,17.ALPHA.,18.BETA.,20.ALPHA.)-11,17-DIMETHOXY-18-(((2E)-1-OXO-3-(3,4,5-TRIMETHOXYPHENYL)-2-PROPEN-1-YL)OXY)-YOHIMBAN-16-CARBOXYLIC ACID METHYL ESTER
  • 3,4,5-TRIMETHOXYCINNAMIC ACID ESTER OF METHYL RESERPATE
  • APOTERIN S
  • CARTRIC
  • CINNALOID
  • METHYL 18.BETA.-HYDROXY-11,17.ALPHA.-DIMETHOXY-3.BETA.,20.ALPHA.-YOHIMBAN-16.BETA.-CARBOXYLATE
  • METHYL 3,4,5-TRIMETHOXYCINNAMOYL RESERPATE
  • MODERIL
  • NSC-15628
  • RESCINNAMINE [HSDB]
  • RESCINNAMINE [INN]
  • RESCINNAMINE [JAN]
  • RESCINNAMINE [MART.]
  • RESCINNAMINE [MI]
  • RESCINNAMINE [ORANGE BOOK]
  • RESCINNAMINE [VANDF]
  • RESCINNAMINE [WHO-DD]
  • RESCISAN
  • RESEALOID
  • RESERPININE
  • SCINNAMINA
  • TSURUSELPI S

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.